Anesth Analg 2002;95:1708-1712
© 2002 International Anesthesia Research Society
PAIN MEDICINE
The Effects of Intrathecal Administration of an Antagonist for Prostaglandin E Receptor Subtype EP1 on Mechanical and Thermal Hyperalgesia in a Rat Model of Postoperative Pain
Keiichi Omote, MD,
Hiroki Yamamoto, MD,
Tomoyuki Kawamata, MD,
Yoshito Nakayama, MD, and
Akiyoshi Namiki, MD
Department of Anesthesiology, Sapporo Medical University School of Medicine, Sapporo, Japan
Address correspondence and reprint requests to Keiichi Omote, MD, Associate Professor, Department of Anesthesiology, Sapporo Medical University School of Medicine, South-1, West-16, Chuoke, Sapporo 060-8543, Japan. Address e-mail to komote{at}sapmed.ac.jp
Despite substantial advances in understanding acute pain mechanisms and in the treatment of pain, postoperative pain, especially mechanically evoked pain (incident pain), is generally not effectively treated. Tissue injury and inflammation increase the release of prostaglandin E2 in the spinal cord, contributing to the development of hyperalgesia. We designed the present study to determine whether the intrathecal administration of an antagonist for prostaglandin E2 receptor subtype EP1, ONO-8711, has an analgesic effect on incision-induced mechanical and thermal hyperalgesia. A 1-cm longitudinal skin incision was made in the plantar aspect of the rat foot. The withdrawal threshold to mechanical stimulation and the withdrawal latency to thermal stimulation applied adjacent to the wound of the hindpaw were investigated. Both mechanical and thermal hyperalgesia were observed at 2 h and 24 h after the incision had been made. ONO-8711 (50, 80, 100 µg) or saline was administered intrathecally. ONO-8711 significantly increased the withdrawal thresholds to mechanical stimulation, but not to thermal stimulation, in a dose- and time-dependent manner. We conclude that EP1 receptor-mediated sensitization of the spinal dorsal horn may contribute to the generation of mechanical, but not thermal, hyperalgesia and that an EP1 receptor antagonist administered intrathecally is a potential analgesic for postoperative pain, especially mechanically evoked pain (incident pain).
IMPLICATIONS: We examined the effects of an intrathecally administered selective EP1 receptor antagonist on mechanical and thermal hyperalgesia in a postoperative pain model. The intrathecal EP1 receptor antagonist inhibited the mechanical, but not thermal, hyperalgesia, indicating the potential for an EP1 receptor antagonist to be used as an analgesic for postoperative pain, especially incident pain.
This article has been cited by other articles:

|
 |

|
 |
 
C.-R. Lin, F. Amaya, L. Barrett, H. Wang, J. Takada, T. A. Samad, and C. J. Woolf
Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity
J. Pharmacol. Exp. Ther.,
December 1, 2006;
319(3):
1096 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|